JMP Securities Downgrades Inhibrx to Market Perform
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Reni Benjamin has downgraded Inhibrx (NASDAQ:INBX) from Market Outperform to Market Perform, indicating a change in the firm's outlook on the stock.

January 23, 2024 | 9:34 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Inhibrx has been downgraded by JMP Securities from Market Outperform to Market Perform, which may lead to a negative perception among investors and potential short-term price decline.
Downgrades by analysts can often lead to a decrease in investor confidence and a subsequent drop in stock price. Since the downgrade is from Market Outperform to Market Perform, it suggests that the stock may no longer outperform the market, which could result in a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100